GDTC Insider Trading Activity and SEC Form 4 Filings
GDTC insider trading summary
Over the past 12 months, insiders at CytoMed Therapeutics Ltd (GDTC) reported 5 open-market purchases worth $729K by 1 insider and no sales on SEC Form 4. Net insider buying was $729K.
Latest GDTC insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 20, 2026 | Chee Kong Choo | Director | Buy | $150K (100,000 @ $1.50) |
| Jul 20, 2026 | Chee Kong Choo | Director | Buy | $150K (100,000 @ $1.50) |
| Jul 14, 2026 | Chee Kong Choo | Director | Buy | $150K (100,000 @ $1.50) |
| Jul 14, 2026 | Chee Kong Choo | Director | Buy | $150K (100,000 @ $1.50) |
| May 13, 2026 | Chee Kong Choo | Director | Buy | $129K (112,000 @ $1.15) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.